Stockreport

Constellation Pharmaceuticals Presentation Highlights Enhanced EZH2 Target Engagement, Leading to Second-Generation EZH2 Inhibitor CPI-0209

Constellation Pharmaceuticals, Inc  (CNST) 
Last constellation pharmaceuticals, inc earnings: 3/10 04:12 pm Check Earnings Report
PDF CAMBRIDGE, Mass., June 12, 2019 (GLOBE NEWSWIRE) -- Constellation Pharmaceuticals, Inc. (Nasdaq: CNST) today announced that Dr. Jacob Stuckey, Senior Scientist at Cons [Read more]